User profiles for Jihan Azar

Jihan Azar

PharmD, MPH, The American University in Cairo
Verified email at aucegypt.edu
Cited by 77

Underrepresented populations in Parkinson's genetics research: current landscape and future directions

…, SC Rao, YZ Zewde, S Dindayal, J Azar… - Movement …, 2022 - Wiley Online Library
Background Human genetics research lacks diversity; over 80% of genome‐wide association
studies have been conducted on individuals of European ancestry. In addition to limiting …

[HTML][HTML] Dysphoric milk ejection reflex: the psychoneurobiology of the breastfeeding experience

R Deif, EM Burch, J Azar, N Yonis… - Frontiers in Global …, 2021 - frontiersin.org
Breastfeeding, given its biochemical and physiological basis, is known for its many benefits
for both the lactating mother and the infant. Among the many challenges new breastfeeding …

Mercury and Alzheimer's disease: a look at the links and evidence

J Azar, MH Yousef, HAN El-Fawal… - Metabolic Brain Disease, 2021 - Springer
This review paper investigates a specific environmental-disease interaction between mercury
exposure and Alzheimer’s disease hallmarks. Alzheimer’s disease is a neurodegenerative …

Gut brain axis: an insight into microbiota role in Parkinson's disease

SA Moustafa, S Mohamed, A Dawood, J Azar… - Metabolic brain …, 2021 - Springer
Parkinson's disease (PD) is one of the most common progressive neurodegenerative diseases.
It is characterized neuropathologically by the presence of alpha-synuclein containing …

Diversity in Parkinson's disease genetics research: current landscape and future directions

…, M Salama, SC Rao, YZ Zewde, S Dindayal, J Azar… - medRxiv, 2021 - medrxiv.org
Human genetics research lacks diversity; over 80% of genome-wide association studies (GWAS)
have been conducted on individuals of European ancestry. In addition to limiting …

Precision health in Alzheimer disease: Risk assessment‐based strategies

J Azar, M Salama, SB Chidambaram… - Precision Medical …, 2021 - Wiley Online Library
Alzheimer disease (AD) is a chronic neurodegenerative condition that affects an individual's
cognitive function over an extended period. Treatment and prevention for AD have long …

The State of Play of Parkinson's Disease in Africa: A Systematic Review and Point of View.

OC Okunoye, YZ Zewde, J Azar, B Ayele, S Dindayal… - medRxiv, 2023 - medrxiv.org
Background: Parkinson's disease (PD) has become a global public health challenge as
disability and death due to the disease are growing rapidly in comparison to other neurological …

The Emerging Role of Vitamin D Deficiency as a Risk Factor of Parkinson's Disease

M El-Gamal, J Azar, R Hegazi - Nutrigenomics and the Brain, 2022 - Springer
Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the
elderly affecting around 1% of individuals older than 65 years of age. PD poses a major health …

Nutrigenomics in Parkinson's Disease

J Azar - Nutrigenomics and the Brain, 2022 - Springer
Parkinson’s disease (PD) is the second most common neurodegenerative disease in the world
(Ball et al. 2019). PD is characterized by the progressive loss of dopaminergic neurons in …

A Preliminary Investigation of Neuroantibody Levels, Prevalence, and Environmental Factors in Patients with Neurological Dysfunction

J Azar - 2022 - fount.aucegypt.edu
Nervous system damage comprises a large proportion of diseases worldwide. It is also the
most difficult to diagnose. Biomarkers for nervous system damage are needed in order to …